Synergistic activity of imatinib and AR-42 against chronic myeloid leukemia cells mainly through HDAC1 inhibition

Wei, DN; Lu, TT; Ma, D; Yu, KL; Zhang, TZ; Xiong, J; Wang, WL; Zhang, ZY; Fang, Q; Wang, JS

Wang, JS (reprint author), Guizhou Med Univ, Dept Hematol, Affiliated Hosp, Guiyang 550004, Guizhou, Peoples R China.; Wang, JS (reprint author), Dept Guizhou Prov Hematopoiet Stem Cell Transplan, Guiyang 550004, Guizhou, Peoples R China.; Wang, JS (repri

LIFE SCIENCES, 2018; 211 (): 224

Abstract

Aims: The aim of this study was to investigate the combinatorial effects of IM and a novel HDAC inhibitor AR-42 on the proliferation, apoptosis, cell ......

Full Text Link